Analysis reveals a dual-function nanoprobe detecting copper and sulfide ions, highlighting its potential for medical diagnostics.
To address the limitations of conventional fluorescent probes, including aggregation-caused quenching (ACQ) and poor water solubility, an intelligent nanoprobe (LPNPs@SA) with tumor microenvironment responsiveness and aggregation-induced emission (AIE) properties was developed. This nanoprobe enables sequential, reversible, and highly sensitive detection of Cu²⁺ and S²⁻. The AIE-active fluorophore salicylaldehyde azine (SA) was designed and synthesized, exhibiting intense emission in aggregated states but poor stability under non-neutral pH conditions. To overcome this limitation, SA was encapsulated into lipid-polymer hybrid nanoparticles (LPNPs) via self-assembly using an amphiphilic copolymer (C₁₆-SS-PEG/DMMA), polycaprolactone (PCL), and phosphatidylcholine (PC). The resulting LPNPs@SA nanoprobe possessed favorable storage stability, broad pH tolerance, effective surface charge conversion, and good hemocompatibility, with a hemolysis rate below 5%. In terms of sensing performance, the nanoprobe showed selective fluorescence quenching ("turn-off" mode) toward Cu²⁺. Stern-Volmer analysis revealed a quenching constant (Ksv) of 2.9 × 10⁵ L/mol. Further fluorescence titration and Job's plot analyses confirmed a 1:1 binding stoichiometry between the nanoprobe and Cu²⁺, with an association constant (Ka) of 2.2 × 10⁴ L/mol. The detection limit (LOD) for Cu²⁺ was determined to be 1.2 μmol/L, demonstrating high sensitivity. Remarkably, upon introducing S²⁻ into the copper-loaded nanoprobe system, substantial fluorescence recovery was observed, yielding a distinct "turn-on" signal for S²⁻ detection. In summary, this work presents a biocompatible nanoprobe with excellent optical properties that functions as an effective reversible fluorescence-switching platform. It offers a promising analytical tool for dynamically monitoring Cu²⁺ and S²⁻ in biological environments, facilitating studies of related pathological processes and potential diagnostic applications.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: